Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 16 ... into a licence agreement with Octapharma (Lachen, Switzerland) to use BAC's anti-Factor IX CaptureSelect® affinity ligand in the large scale purification of recombinant ...
2009 NOV 23 ... According to recent research from Leipzig, Germany, "Recombinant human granulocyte colony-stimulatingfactor (rhG-CSF) is widely used as treatment for granulocytopaenia during cytotoxic ...
2009 NOV 23 ... A report, 'Pharmacokinetic and pharmacodynamic modelling of the novel human granulocyte colony-stimulatingfactor derivative Maxy-G34 and pegfilgrastim in rats,' is newly published data in Cell ...
2009 NOV 16 ... days 1-3 of weeks 1, 3, 5, 7 and 9. Chemotherapy courses were supported by granulocyte colony-stimulatingfactor. Post-protocol local therapy was allowed. From July 1997 to March 2004, 30 ...
2009 NOV 16 ... 4 (CTLA-4) and vaccination with irradiated B16 tumor expressing granulocyte macrophage colony-stimulatingfactor (GM-CSF; Gvax) promotes rejection of established murine melanomas. Here we show ...
2009 NOV 23 ... as an in vitro ischemia model. Fasudil stimulates astrocytes to produce granulocyte colony-stimulatingfactor (G-CSF). Astrocyte-conditioned medium treated with Fasudil (ACM-F) contributes to ...
2009 NOV 23 ... agent antithymocyte globulin (ATG), as well as the mobilization agent granulocyte colony-stimulatingfactor (GCSF), to reverse overt hyperglycemia in the nonobese diabetic (NOD) mouse model ...
2009 NOV 16 ... Murine Pulmonary Neutrophilia Mainly through Effects on Macrophage-Derived Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-1 beta. Journal of Pharmacology and Experimental Therapeutics, ...
2009 NOV 16 ... in a murine colitis model. Human peripheral blood CD14(+) monocytes were cultured with granulocyte-macrophage colony stimulation factor and interleukin (IL)-4, with or without synthetic RA, Am80. ...
2009 NOV 23 ... complex class II and 33D1, but not CD11b. Systemic injection of granulocyte/macrophage colony-stimulatingfactor (GM-CSF) markedly increased cell proliferation in early lesions, whereas ...
2009 NOV 23 ... model of fibrosarcoma. Bone-marrow derived DCs (BMDCs) were cultured in the presence of granulocyte-macrophage colony-stimulating factor and interleukin-4. After 5 days, tumor lysates with or without the T. gondii lysate were ...
2009 NOV 16 ... According to a study from Bern, Switzerland, "The efficacy of granulocyte colony-stimulatingfactor (G-CSF) for coronary collateral growth promotion and thus impending myocardial ...
2009 NOV 9 ... There was no significant difference in the frequency of granulocyte colony stimulating factor usage and recovery time of absolute neutrophil count and platelet count. The incidence ...
2009 NOV 16 ... vascular endothelial growth factor, stromal derived factor-1 (SDF-1), and granulocyte colony-stimulatingfactor (G-CSF) levels are detected. With the aim of determining whether G-CSF is ...
2009 NOV 16 ... blood (mPB) CD34(+) cells into NOD/SCID mice, reduced numbers of PMF CD34(+) cells and granulocyte-macrophage colony-forming unit (CFU-GM) compared with mPB were detected in the marrow of these ... Research report. "Following the infusion of PMF and normal granulocyte colony-stimulatingfactor-mobilized peripheral blood (mPB) CD34(+) cells into NOD/SCID mice, reduced ...
2009 NOV 23 ... eight patients, IP occurred during the administration of granulocyte-colony stimulating factor. RTX seems to have a certain risk to induce IP including PCP," wrote H. Katsuya and ...
2009 NOV 23 ... interaction chromatography (HIC) mode to refold recombinant human granulocyte colony-stimulatingfactor from its inclusion bodies at high protein concentration." "The ...
2009 NOV 9 ... in first or second complete or partial remission were eligible. received granulocyte colony-stimulatingfactor (G-CSF; 10 mu g/kg) subcutaneously daily for up to 8 days. Beginning on evening ...
